Submit a Review & Earn an Amazon Gift Card
You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!
Submit Review0832 has been discontinued.
View all Non-selective Adrenergic β Receptors products.β-adrenergic antagonist and low efficacy partial agonist; does not affect resting cardiac parameters.
Sold with the permission of AstraZeneca UK Ltd.
M. Wt | 354.41 |
Formula | C19H22N4O3 |
Storage | Store at RT |
Purity | ≥99% (HPLC) |
CAS Number | 53671-71-9 |
PubChem ID | 123686 |
InChI Key | HTLWRKRZKFAAAH-UHFFFAOYSA-N |
Smiles | OC(CNCCNC(=O)NC1=CC=CC=C1)COC1=C(C=CC=C1)C#N |
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
References are publications that support the biological activity of the product.
Mai (1990) β-Adrenergic Receptors. Comprehensive Medicinal Chemistry. Ed. Hansch. 3 187
Keywords: ICI 89406, ICI 89406 supplier, β-adrenoceptor, beta-adrenoceptor, b-adrenoceptor, β-adrenergic, beta-adrenergic, b-adrenergic, antagonists, Receptors, Non-Selective, ICI89406, AstraZeneca, Non-selective, Adrenergic, Beta, 0832, Tocris Bioscience
Citations are publications that use Tocris products. Selected citations for ICI 89406 include:
Mistry et al (2013) Synthesis and in vitro and in vivo characterization of highly β1-selective β-adrenoceptor partial agonists. J Med Chem 56 3852 PMID: 23614528
Kaya et al (2009) Coupling of β2-adrenoceptors to XLαs and Gαs: a new insight into ligand-induced G protein activation. J Pharmacol Exp Ther 329 350 PMID: 19144685
There are currently no reviews for this product. Be the first to review ICI 89406 and earn rewards!
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.
Major depressive disorder is characterized by depressed mood and a loss of interest and/or pleasure. Updated in 2015 this poster highlights presynaptic and postsynaptic targets for the potential treatment of major depressive disorder, as well as outlining the pharmacology of currently approved antidepressant drugs.